4/A//SEC Filing
Sosnowski Robert Edward 4/A
Accession 0001209191-09-002349
CIK 0001130166other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 11:43 AM ET
Size
6.4 KB
Accession
0001209191-09-002349
Insider Transaction Report
Form 4/AAmended
Sosnowski Robert Edward
VP, Marketing & Sales
Transactions
- Award
Option
2008-11-18+100,000→ 100,000 totalExercise: $0.44Exp: 2018-11-18→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]These options are exercisable over a three-year period, with one-third (1/3) of the options granted vesting on November 18, 2009, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 24 months.
- [F2]These securities were issued as part of the Issuer's annual equity compensation to executive officers.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001450497
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 11:43 AM ET
- Size
- 6.4 KB